Becton Dickinson Total Liabilities and Share Holders Equity 2010-2024 | BDX
Becton Dickinson total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- Becton Dickinson total liabilities and share holders equity for the quarter ending September 30, 2024 was $55.582B, a 4.84% increase year-over-year.
- Becton Dickinson total liabilities and share holders equity for 2023 was $52.78B, a 0.29% decline from 2022.
- Becton Dickinson total liabilities and share holders equity for 2022 was $52.934B, a 1.73% decline from 2021.
- Becton Dickinson total liabilities and share holders equity for 2021 was $53.866B, a 0.27% decline from 2020.
Becton Dickinson Annual Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2023 |
$52,780 |
| 2022 |
$52,934 |
| 2021 |
$53,866 |
| 2020 |
$54,012 |
| 2019 |
$51,765 |
| 2018 |
$53,904 |
| 2017 |
$37,734 |
| 2016 |
$25,586 |
| 2015 |
$26,478 |
| 2014 |
$12,447 |
| 2013 |
$12,149 |
| 2012 |
$11,361 |
| 2011 |
$10,430 |
| 2010 |
$9,651 |
| 2009 |
$9,305 |
Becton Dickinson Quarterly Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024-06-30 |
$55,582 |
| 2024-03-31 |
$54,157 |
| 2023-12-31 |
$52,274 |
| 2023-09-30 |
$52,780 |
| 2023-06-30 |
$53,017 |
| 2023-03-31 |
$54,394 |
| 2022-12-31 |
$53,129 |
| 2022-09-30 |
$52,934 |
| 2022-06-30 |
$53,199 |
| 2022-03-31 |
$54,786 |
| 2021-12-31 |
$53,363 |
| 2021-09-30 |
$53,866 |
| 2021-06-30 |
$54,333 |
| 2021-03-31 |
$54,921 |
| 2020-12-31 |
$54,748 |
| 2020-09-30 |
$54,012 |
| 2020-06-30 |
$53,959 |
| 2020-03-31 |
$53,516 |
| 2019-12-31 |
$51,952 |
| 2019-09-30 |
$51,765 |
| 2019-06-30 |
$52,233 |
| 2019-03-31 |
$52,598 |
| 2018-12-31 |
$52,932 |
| 2018-09-30 |
$53,904 |
| 2018-06-30 |
$53,977 |
| 2018-03-31 |
$54,573 |
| 2017-12-31 |
$55,363 |
| 2017-09-30 |
$37,734 |
| 2017-06-30 |
$37,166 |
| 2017-03-31 |
$24,121 |
| 2016-12-31 |
$24,318 |
| 2016-09-30 |
$25,586 |
| 2016-06-30 |
$26,016 |
| 2016-03-31 |
$26,236 |
| 2015-12-31 |
$26,046 |
| 2015-09-30 |
$26,478 |
| 2015-06-30 |
$27,079 |
| 2015-03-31 |
$28,293 |
| 2014-12-31 |
$18,503 |
| 2014-09-30 |
$12,447 |
| 2014-06-30 |
$12,374 |
| 2014-03-31 |
$12,250 |
| 2013-12-31 |
$12,035 |
| 2013-09-30 |
$12,149 |
| 2013-06-30 |
$11,587 |
| 2013-03-31 |
$11,630 |
| 2012-12-31 |
$11,629 |
| 2012-09-30 |
$11,361 |
| 2012-06-30 |
$11,025 |
| 2012-03-31 |
$11,195 |
| 2011-12-31 |
$11,413 |
| 2011-09-30 |
$10,430 |
| 2011-06-30 |
$10,621 |
| 2011-03-31 |
$10,344 |
| 2010-12-31 |
$10,071 |
| 2010-09-30 |
$9,651 |
| 2010-06-30 |
$9,032 |
| 2010-03-31 |
$8,943 |
| 2009-12-31 |
$9,094 |
| 2009-09-30 |
$9,305 |
| 2009-06-30 |
$8,849 |
| 2009-03-31 |
$7,576 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$64.352B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
